These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2856532)

  • 21. Risk of cytomegalovirus transmission by blood products to immunocompromised patients and means for reduction.
    Ljungman P
    Br J Haematol; 2004 Apr; 125(2):107-16. PubMed ID: 15059132
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cytomegalovirus and blood transfusion].
    Eggen BM
    Tidsskr Nor Laegeforen; 1993 Jan; 113(1):22-4. PubMed ID: 8380944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytomegalovirus infection following stem cell transplantation.
    Einsele H; Hebart H
    Haematologica; 1999 Jun; 84 Suppl EHA-4():46-9. PubMed ID: 10907466
    [No Abstract]   [Full Text] [Related]  

  • 24. [Human cytomegalovirus--biology and infection].
    Geginat G; Hampl W; Mertens T
    Med Klin (Munich); 1992 Oct; 87 Suppl 1():3-10. PubMed ID: 1334219
    [No Abstract]   [Full Text] [Related]  

  • 25. The blood donor: detection and magnitude of cytomegalovirus carrier states and the prevalence of cytomegalovirus antibody.
    Bayer WL; Tegtmeier GE
    Yale J Biol Med; 1976 Mar; 49(1):5-12. PubMed ID: 183381
    [No Abstract]   [Full Text] [Related]  

  • 26. Survey on Transfusion-Transmitted Cytomegalovirus and Cytomegalovirus Disease Mitigation.
    Weisberg SP; Staley EM; Williams LA; Pham HP; Bachegowda LS; Cheng YH; Schwartz J; Shaz BH
    Arch Pathol Lab Med; 2017 Dec; 141(12):1705-1711. PubMed ID: 28849943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nosocomial transmission of cytomegalovirus.
    Adler SP
    Pediatr Infect Dis; 1986; 5(2):239-46. PubMed ID: 3006000
    [No Abstract]   [Full Text] [Related]  

  • 28. Preventing transfusion-acquired cytomegalovirus infection in infants.
    Lancet; 1989 Jul; 2(8655):160-1. PubMed ID: 2567924
    [No Abstract]   [Full Text] [Related]  

  • 29. Cytomegalovirus infection in a neonatal intensive care unit. Subsequent morbidity and mortality of seropositive infants.
    Griffin MP; O'Shea M; Brazy JE; Klein D; Koepke J; Malloy C; Wilfert CM
    J Perinatol; 1990 Mar; 10(1):43-5. PubMed ID: 2156031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antibodies to cytomegaloviruses in blood donors].
    Courault K; Lissé I; Richter H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(2):183-6. PubMed ID: 2475395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Donor serostatus and CMV infection and disease among recipients of prophylactic granulocyte transfusions.
    Nichols WG; Price T; Boeckh M
    Blood; 2003 Jun; 101(12):5091-2; author reply 5092. PubMed ID: 12788795
    [No Abstract]   [Full Text] [Related]  

  • 32. Cytomegalovirus (CMV): the agent, its pathogenesis, and its epidemiology.
    Lamberson HV
    Prog Clin Biol Res; 1985; 182():149-73. PubMed ID: 2994096
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cytomegalovirus infections following heart surgery. A prospective study of specific antibodies].
    Zegelman M; Satter P; Giesel M
    Helv Chir Acta; 1987 Feb; 53(4):501-4. PubMed ID: 3032867
    [No Abstract]   [Full Text] [Related]  

  • 34. Congenital cytomegalovirus screening.
    Adler SP
    Pediatr Infect Dis J; 2005 Dec; 24(12):1105-6. PubMed ID: 16371874
    [No Abstract]   [Full Text] [Related]  

  • 35. Frozen deglycerolyzed blood prevents transfusion-acquired cytomegalovirus infections in neonates.
    Taylor BJ; Jacobs RF; Baker RL; Moses EB; McSwain BE; Shulman G
    Pediatr Infect Dis; 1986; 5(2):188-91. PubMed ID: 3005998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Window period donations during primary cytomegalovirus infection and risk of transfusion-transmitted infections.
    Ziemann M; Heuft HG; Frank K; Kraas S; Görg S; Hennig H
    Transfusion; 2013 May; 53(5):1088-94. PubMed ID: 23320406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytomegalovirus infection in cancer patients receiving granulocyte transfusions.
    Narvios A; Pena E; Han XY; Lichtiger B
    Blood; 2002 Jan; 99(1):390-1. PubMed ID: 11783435
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prevalence of anti-CMV antibodies in blood donors in the Sfax region (value in blood transfusion)].
    Gargouri J; Elleuch H; Karray H; Rekik H; Hammami A
    Tunis Med; 2000; 78(8-9):512-7. PubMed ID: 11190729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transfusion support using filtered unscreened blood products for cytomegalovirus-negative allogeneic marrow transplant recipients.
    Narvios AB; Przepiorka D; Tarrand J; Chan KW; Champlin R; Lichtiger B
    Bone Marrow Transplant; 1998 Sep; 22(6):575-7. PubMed ID: 9758346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New approaches and perspectives in cytomegalovirus diagnosis.
    Landini MP
    Prog Med Virol; 1993; 40():157-77. PubMed ID: 8382370
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.